Cancer UCL

Overview

The Cancer MSc at UCL is a one-year full-time programme that provides an in-depth understanding of cancer biology and the mechanisms behind the development and progression of cancer. The course reflects the wide range of research areas within the UCL Cancer Institute, covering topics from basic cancer science to translational medicine.

Why Cancer at UCL?

UCL stands out as one of Europe's foremost centres for biomedical science, renowned for its impactful research in both basic and clinical cancer studies. The UCL Cancer Institute fosters a collaborative environment where scientists and clinicians work together to drive advancements in cancer research. The institute's strengths encompass a wide array of topics, including molecular pathology, cancer signalling pathways, epigenetics, targeted therapies, and clinical trials. Students benefit from access to state-of-the-art facilities and a curriculum designed by leading experts in the field.

Tuition Fee Breakdown

For the academic year 2026/27, the tuition fees for the Cancer MSc are as follows:

• National students: £20,500 per year
• International students: £39,800 per year

Visit the Fees and Funding section for a breakdown in your local currency.

Syllabus

The Cancer MSc programme consists of five taught modules and a compulsory research dissertation, totalling 180 credits. The modules include:

• Basic Biology and Cancer Genetics
• Cancer Therapeutics
• Optional modules such as Cancer Immunology and Immunotherapy, Multi-Omics and Cancer Evolution, Behavioural Science in Cancer, and Cancer Clinical Trials
• Cancer Research Skills (compulsory)

In the first term, students will focus on fundamental cancer biology and treatment strategies. The second term allows for exploration of behavioural science and clinical trials, culminating in a research project where students apply their knowledge in a practical setting.

Guaranteed Work Experience

The programme includes a mandatory 3.5-month research project, providing students with hands-on experience in a research-intensive environment. This opportunity is designed to enhance practical skills and prepare students for future roles in cancer research.

Careers with Cancer

Graduates of the Cancer MSc have a promising career outlook, with approximately 89% of alumni either employed or pursuing further studies. Many have secured positions in NHS and private hospitals, cancer research organisations, clinical research firms, and pharmaceutical companies. Specific employers include Cancer Research UK, Merck Sharp & Dohme, and various universities. Roles taken by graduates range from biochemists and biomedical scientists to data analysts and medical communications professionals. The programme's strong emphasis on networking and practical experience facilitates successful transitions into the workforce or further academic pursuits.